BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1980266)

  • 41. Urinary N-methylhistamine in asthmatic children receiving azelastine hydrochloride.
    Takei S; Shimago A; Iwashita M; Kumamoto T; Kamuro K; Miyata K
    Ann Allergy Asthma Immunol; 1997 May; 78(5):492-6. PubMed ID: 9164363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical active H1-antihistamines and their effect on nasal airway resistance.
    van Houten RJ; Premachandra DJ
    J Laryngol Otol; 1995 Sep; 109(9):841-3. PubMed ID: 7494116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different, dose-dependent effects of verapamil inhalation on histamine-induced bronchoconstriction in anaesthetized dogs.
    Krivoy N; Brandt HD; Bunn AE
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):328-34. PubMed ID: 6143539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effects of a new antiallergic agent, azelastine, on passive cutaneous anaphylaxis and expulsion of Nippostrongylus brasiliensis.
    Kaji R; Kamijo T; Kojima S
    Immunopharmacology; 1981 Feb; 3(1):49-52. PubMed ID: 6112210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azelastine: a multifaceted drug for asthma therapy.
    Szelenyi I; Achterrath-Tuckermann U; Schmidt J; Minker E; Paegelow I; Werner H
    Agents Actions Suppl; 1991; 34():295-311. PubMed ID: 1686526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis.
    Friedman BS; Santiago ML; Berkebile C; Metcalfe DD
    J Allergy Clin Immunol; 1993 Oct; 92(4):520-6. PubMed ID: 8104966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azelastine inhibits agonist-induced electromechanical activity in canine tracheal muscle.
    Lee HK; Sperelakis N
    Chest; 1989 Sep; 96(3):665-9. PubMed ID: 2569961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of effect of azelastine and ketoconazole coadministration on electrocardiographic parameters in healthy volunteers.
    Morganroth J; Lyness WH; Perhach JL; Mather GG; Harr JE; Trager WF; Levy RH; Rosenberg A
    J Clin Pharmacol; 1997 Nov; 37(11):1065-72. PubMed ID: 9506001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers.
    Rolan PE; Phillips S; Adams J; Posner J
    Eur J Clin Pharmacol; 1990; 39(3):311-3. PubMed ID: 1979541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamic evaluation of azelastine in subjects with asthma.
    Spector SL; Perhach JL; Rohr AS; Rachelefsky GS; Katz RM; Siegel SC
    J Allergy Clin Immunol; 1987 Jul; 80(1):75-80. PubMed ID: 3298379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of azelastine on acute radiation dermatitis in mice models.
    Murakami R; Baba Y; Nishimura R; Furusawa M; Yokoyama T; Yamashita Y; Takahashi M; Yamashita N; Ono T
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):907-11. PubMed ID: 9128968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cough threshold for capsaicin increases by azelastine in patients with cough-variant asthma.
    Shioya T; Ito N; Sasaki M; Kagaya M; Sano M; Shindo T; Kashima M; Miura M
    Pulm Pharmacol; 1996 Feb; 9(1):59-62. PubMed ID: 8843511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time-dependent effect of prostaglandin E2 inhalation on airway responses to bronchoconstrictor agents in normal subjects.
    Walters EH; Bevan C; Parrish RW; Davies BH; Smith AP
    Thorax; 1982 Jun; 37(6):438-42. PubMed ID: 6753224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duration of action of a single dose of azelastine in patients with chronic asthma.
    Chervinsky P; Grossman J; Freitag JJ
    J Asthma; 1995; 32(2):141-5. PubMed ID: 7559264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing.
    Ollier S; Gould CA; Davies RJ
    J Allergy Clin Immunol; 1986 Aug; 78(2):358-64. PubMed ID: 3734289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma.
    Nieber K; Baumgarten C; Rathsack R; Furkert J; Laake E; Müller S; Kunkel G
    Clin Exp Allergy; 1993 Jan; 23(1):69-71. PubMed ID: 7679943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Action of azelastine on intracellular Ca2+ in cultured airway smooth muscle.
    Senn N; Jeanclos E; Garay R
    Eur J Pharmacol; 1991 Nov; 205(1):29-34. PubMed ID: 1687465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of budesonide and azelastine on histamine signaling regulation in human nasal epithelial cells.
    Liu SC; Lin CS; Chen SG; Chu YH; Lee FP; Lu HH; Wang HW
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):845-853. PubMed ID: 27623823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of azelastine on IL-1 beta generation in vitro and IL-1 beta-induced effect in vivo.
    Werner U; Schmidt J; Szelenyi I
    Agents Actions Suppl; 1991; 32():243-7. PubMed ID: 1676876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-chlamydial effects of azelastine hydrochloride and the impact of the histamine H1 receptor on chlamydial development.
    Kuratli J; Leonard CA; Schoborg R; Borel N
    J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37195751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.